INTRODUCTION: Severe sepsis and septic shock are common problems in the intensive care unit and carry a high mortality. Endotoxin, one of the principal components on the outer membrane of gram-negative bacteria, is considered important to their pathogenesis. Polymyxin B bound and immobilized to polystyrene fibers (PMX-F) is a medical device that aims to remove circulating endotoxin by adsorption, theoretically preventing the progression of the biological cascade of sepsis. We performed a systematic review to describe the effect in septic patients of direct hemoperfusion with PMX-F on outcomes of blood pressure, use of vasoactive drugs, oxygenation, and mortality reported in published studies. METHODS: We searched PubMed, the Cochrane Collaboration Database, and bibliographies of retrieved articles and consulted with experts to identify relevant studies. Prospective and retrospective observational studies, pre- and post-intervention design, and randomized controlled trials were included. Three authors reviewed all citations. We identified a total of 28 publications - 9 randomized controlled trials, 7 non-randomized parallel studies, and 12 pre-post design studies - that reported at least one of the specified outcome measures (pooled sample size, 1,425 patients: 978 PMX-F and 447 conventional medical therapy). RESULTS: Overall, mean arterial pressure (MAP) increased by 19 mm Hg (95% confidence interval [CI], 15 to 22 mm Hg; p < 0.001), representing a 26% mean increase in MAP (range, 14% to 42%), whereas dopamine/dobutamine dose decreased by 1.8 microg/kg per minute (95% CI, 0.4 to 3.3 microg/kg per minute; p = 0.01) after PMX-F. There was significant intertrial heterogeneity for these outcomes (p < 0.001), which became non-significant when analysis was stratified for baseline MAP. The mean arterial partial pressure of oxygen/fraction of inspired oxygen (PaO2/FiO2) ratio increased by 32 units (95% CI, 23 to 41 units; p < 0.001). PMX-F therapy was associated with significantly lower mortality risk (risk ratio, 0.53; 95% CI, 0.43 to 0.65). The trials assessed had suboptimal method quality. CONCLUSION: Based on this critical review of the published literature, direct hemoperfusion with PMX-F appears to have favorable effects on MAP, dopamine use, PaO2/FiO2 ratio, and mortality. However, publication bias and lack of blinding need to be considered. These findings support the need for further rigorous study of this therapy.
Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review / Cruz, Dn; Perazella, Ma; Bellomo, R; DE CAL, M; Polanco, N; Corradi, V; Lentini, P; Nalesso, F; Ueno, T; Ranieri, VITO MARCO; Ronco, C.. - In: CRITICAL CARE. - ISSN 1466-609X. - STAMPA. - 11(2)(2007), pp. R47-R47.
Scheda prodotto non validato
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo
|Titolo:||Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review.|
|Data di pubblicazione:||2007|
|Citazione:||Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review / Cruz, Dn; Perazella, Ma; Bellomo, R; DE CAL, M; Polanco, N; Corradi, V; Lentini, P; Nalesso, F; Ueno, T; Ranieri, VITO MARCO; Ronco, C.. - In: CRITICAL CARE. - ISSN 1466-609X. - STAMPA. - 11(2)(2007), pp. R47-R47.|
|Appartiene alla tipologia:||01a Articolo in rivista|